Ambelvist 0.1 mmol/ ml, Injektionslösung in einer Durchstechflasche

7680704050018 CH-70405 Injektionslösung

Associated product:

AMBELVIST 0.1 mmol/ ml sol inj 30 ml

No image available

Article details

Package size
30
Selling units
30
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
10/09/2026
Summary of Product Characteristics
Français
10/09/2026
Summary of Product Characteristics
Italien
10/09/2026

Detailed composition

Substance Quantity Type Category
gadoquatranum
257.9 MG Substance Wirkstoff (Principe actif)
gadolinium
62.9 MG Substance WIIS
calcobutrolum
- Substance HNIDK
trometamolum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.235 MG Substance HBESI

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
70405
Drug name
Ambelvist, Injektionslösung in einer Durchstechflasche
Galenic form
LSINJ
ATC Code
V08CA13
Authorization status
Z
Dispensing category
B
First authorization
28/08/2026
Authorization expiration date
27/08/2031
IT Number
14.02.0.
Domain
Human medicine
Field of application
MRT-Kontrastmittel für die ZNS-Diagnostik und weitere Körperregionen

Package details

Description (FR)
AMBELVIST 0.1 mmol/ ml sol inj 30 ml
Description (DE)
AMBELVIST 0.1 mmol/ ml Inj Lös 30 ml
Market launch
01/11/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data